Bookimed does not add extra charges for Chemotherapy prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your Chemotherapy upon your arrival.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemotherapy journey.
Centro Médico Teknon, renowned for its outstanding oncology department, follows strict American standards from the Memorial Sloan Kettering Cancer Center. The institution's oncology specialists, led by Prof. Raimon Miralbell, offer individualized chemotherapy treatments. Teknon holds prestigious accreditations like Joint Commission International and European Foundation for Quality Management. Located in a high-end district, it is close to Barcelona's attractions. The clinic's environment is modern, clean, and patient-friendly, ensuring comprehensive care and comfort.
SJD Barcelona Children's Hospital ranks among Europe's top 5 medical institutions, excelling in pediatric oncology. The hospital's oncology center pioneered intra-arterial chemotherapy for retinoblastoma, preserving the eye. The survival rate for acute lymphoblastic leukemia is 84%. Allogeneic bone marrow transplants from related donors have a 90-100% survival rate. The hospital is accredited by the National Board of Health in Spain and part of NACHRI. Nearby, patients can visit the beautiful Park Güell.
Hospital Quiron Barcelona is recognized for its oncology expertise through the Baselga Institute of Oncology. It collaborates with leading American centers. The hospital holds Joint Commission International accreditation, ensuring high medical standards. It features advanced technology like PET-CT and MRI for precise treatments. The facility has 23 operating rooms and 2 linear accelerators. International patients receive personalized care in 165 wards. Nearby, patients can explore attractions like Park Güell and Sagrada Família.
Hospital HM Nou Delfos is part of Spain's largest medical network, HM Hospitals. The clinic holds certifications like the European Foundation for Quality Management and ISO 9001. It is equipped with advanced CT and MRI, offering accurate diagnostics. The clinic collaborates with Institut Guttmann, a JCI-accredited neurorehabilitation hospital. Located in Barcelona, patients can explore nearby attractions like Park Güell. The clinic's comprehensive care and quality accreditations make it a reliable choice for chemotherapy.
The operation heats chemotherapy drugs and applies them directly inside the belly to kill hidden cancer cells.
This therapy targets and kills cancer cells in the liver, using drugs given by mouth or injection.
This therapy utilizes drugs to kill lung cancer cells, often given via injection or oral tablet, enhancing survival rates.
This therapy targets and destroys breast cancer cells, using powerful drugs, enhancing survival and recovery rates.
Day 1
Day 2
Day 3 - Day 5
Week 2
Week 3
Week 4 - Week 6
Week 7 onwards
Please note that each patient"s case is individual. The treatment plan and recovery time can vary based on the individual"s health status and response to treatment.
Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.
This doctor has experience in endocrine treatment, collaborating on studies aimed at overcoming resistance to hormone therapy. They have also been involved in numerous phase 1, 2 and 3 studies in breast and melanoma, which have led to the approval of new drugs in new indications. Their main area of interest lies in immunotherapy for melanoma treatment and patient care. They have participated in trials that have led to the approval of cdk4/6 palbociclib and ribociclib inhibitors in the first line of metastatic breast cancer, and Pembrolizumab in the first line of metastatic melanoma, as well as the combination of Nivolumab and Ipilimumab. They are a member of the Breast Cancer Unit and Melanoma Unit at the Vall d'Hebron University Hospital and the Vall d'Hebron Institute of Oncology. This doctor is an experienced oncologist with expertise in breast cancer and melanoma treatments, including endocrine therapy, immunotherapy, and patient care. They have been involved in numerous clinical trials leading to the approval of new drugs in new indications.